{"component": "definition", "props": {"groups": [{"size": 5, "snippet": "is a Study Subject who is not enrolled into the Study because he or she does not meet all inclusion and exclusion criteria or other requirements that must be met for participation in the Study. \u201eP\u0159\u00edpadem ne\u00fasp\u011b\u0161n\u00e9ho screeningu\u201c se rozum\u00ed Subjekt studie, kter\u00fd nebyl do Studie zaps\u00e1n, jeliko\u017e nevyhov\u011bl v\u0161em krit\u00e9ri\u00edm pro za\u0159azen\u00ed a vylou\u010den\u00ed nebo jin\u00fdm po\u017eadavk\u016fm, kter\u00e9 mus\u00ed b\u00fdt k \u00fa\u010dasti ve Studii spln\u011bny.", "snippet_links": [{"key": "study-subject", "type": "definition", "offset": [5, 18]}, {"key": "does-not-meet", "type": "definition", "offset": [72, 85]}, {"key": "inclusion-and-exclusion-criteria", "type": "clause", "offset": [90, 122]}, {"key": "other-requirements", "type": "clause", "offset": [126, 144]}, {"key": "in-the-study", "type": "clause", "offset": [180, 192]}], "samples": [{"hash": "gCjqhL2jIsP", "uri": "/contracts/gCjqhL2jIsP#screen-failure", "label": "Clinical Trial Agreement", "score": 34.4498737097, "published": true}, {"hash": "flOxs0nGhNA", "uri": "/contracts/flOxs0nGhNA#screen-failure", "label": "Clinical Trial Agreement", "score": 34.0451386535, "published": true}], "hash": "8570ac5e5464153d7df58917953e3def", "id": 1}, {"size": 5, "snippet": "means a Study subject for whom the screening has been performed, including signing the specific Informed Consent Form, but who could not be effectively included in the Study under the exclusion/inclusion criteria set forth in the Protocol for enrolment (ruxolitinib run-in period) or for other justified reasons. \"\"Pre-Randomization Failure\"\" shall mean study subject enrolled into the ruxolitinib run- in part of the study but who could not be effectively randomized in the study under the inclusion/exclusion criteria set forth in the Protocol for randomization. Sponsor, through PSI shall pay in total for 3 (three) Screen Failure subjects in accordance with per- procedure costs listed in respective table (Screen Failure), after which Sponsor's approval (email shall suffice) will be required to resume screening procedures. Sponsor, through PSI shall pay for each Pre- Randomization Failure subjects in accordance with per-procedure costs listed in respective table (Pre- Randomization Failure). An enrollment cap may be implemented by the Sponsor on screening at the site (e-mail shall suffice) if 5 or more Study subjects at the Institution are enrolled into the run-in period and 80% or more of them are not suitable for the randomized add-on period.\" Za \"Ne\u00fasp\u011b\u0161n\u00fd screening\" bude pova\u017eov\u00e1n screening Subjektu hodnocen\u00ed proveden\u00fd v\u010detn\u011b podpisu konkr\u00e9tn\u00edho Informovan\u00e9ho souhlasu, kdy v\u0161ak subjekt nemohl b\u00fdt efektivn\u011b za\u0159azen do Studie dle krit\u00e9ri\u00ed pro ne/za\u0159azen\u00ed uveden\u00fdch v Protokolu pro n\u00e1bor (p\u0159\u00edpravn\u00e9 obdob\u00ed s ruxolitinibem) nebo z jin\u00e9ho opr\u00e1vn\u011bn\u00e9ho d\u016fvodu. Za \"Ne\u00fasp\u011b\u0161n\u00fd screening subjektu p\u0159ed randomizac\u00ed\" bude pova\u017eov\u00e1n screening subjektu hodnocen\u00ed za\u0159azen\u00e9ho do p\u0159\u00edpravn\u00e9ho obdob\u00ed s ruxolitinibem, kdy v\u0161ak subjekt nemohl b\u00fdt efektivn\u011b randomizov\u00e1n do studie dle krit\u00e9ri\u00ed pro ne/za\u0159azen\u00ed uveden\u00fdch v Protokolu pro randomizaci. Zadavatel prost\u0159ednictv\u00edm PSI zaplat\u00ed celkem 3 (t\u0159i) Ne\u00fasp\u011b\u0161n\u00e9 screeningy v souladu s rozpisem n\u00e1klad\u016f na jednotliv\u00e9 procedury uveden\u00fdm v p\u0159\u00edslu\u0161n\u00e9 tabulce (Ne\u00fasp\u011b\u0161n\u00fd screening) a pot\u00e9 bude k pokra\u010dov\u00e1n\u00ed ve screeningov\u00fdch procedur\u00e1ch zapot\u0159eb\u00ed souhlas Zadavatele (posta\u010d\u00ed emailem). Zadavatel prost\u0159ednictv\u00edm PSI uhrad\u00ed n\u00e1klady za v\u0161echny Ne\u00fasp\u011b\u0161n\u011b za\u0159azen\u00e9 subjekty p\u0159ed randomizac\u00ed v souladu s rozpisem n\u00e1klad\u016f za jednotliv\u00e9 procedury uveden\u00fdm v p\u0159\u00edslu\u0161n\u00e9 tabulce (Ne\u00fasp\u011b\u0161n\u011b za\u0159azen\u00fd subjekt p\u0159ed randomizac\u00ed). Zadavatel sm\u00ed nastavit strop pro n\u00e1bor subjekt\u016f pro screening v centru (posta\u010d\u00ed emailem), pokud bude Zdravotnick\u00fdm za\u0159\u00edzen\u00edm nabr\u00e1no do p\u0159\u00edpravn\u00e9ho obdob\u00ed Studie 5 a v\u00edce subjekt\u016f a 80% z nich \u010di v\u00edce nebudou spl\u0148ovat krit\u00e9ria pro randomizaci do obdob\u00ed s p\u0159\u00eddavnou l\u00e9\u010dbou.", "snippet_links": [{"key": "informed-consent-form", "type": "definition", "offset": [96, 117]}, {"key": "in-the-study", "type": "clause", "offset": [161, 173]}, {"key": "inclusion-criteria", "type": "clause", "offset": [194, 212]}, {"key": "the-protocol", "type": "clause", "offset": [226, 238]}, {"key": "in-period", "type": "clause", "offset": [270, 279]}, {"key": "exclusion-criteria", "type": "definition", "offset": [501, 519]}, {"key": "in-total", "type": "clause", "offset": [596, 604]}, {"key": "in-accordance-with", "type": "definition", "offset": [643, 661]}, {"key": "screening-procedures", "type": "clause", "offset": [808, 828]}, {"key": "pay-for", "type": "definition", "offset": [857, 864]}, {"key": "enrollment-cap", "type": "definition", "offset": [1005, 1019]}, {"key": "the-sponsor", "type": "clause", "offset": [1042, 1053]}, {"key": "the-site", "type": "clause", "offset": [1070, 1078]}, {"key": "study-subjects", "type": "definition", "offset": [1115, 1129]}, {"key": "the-institution", "type": "clause", "offset": [1133, 1148]}, {"key": "ne\u00fasp\u011b\u0161n\u00fd-screening", "type": "clause", "offset": [1265, 1284]}, {"key": "n\u00e1bor-subjekt\u016f", "type": "clause", "offset": [2396, 2410]}, {"key": "zdravotnick\u00fdm-za\u0159\u00edzen\u00edm", "type": "clause", "offset": [2464, 2487]}], "samples": [{"hash": "aNip12AybV5", "uri": "/contracts/aNip12AybV5#screen-failure", "label": "Clinical Study Agreement", "score": 35.6993009781, "published": true}], "hash": "d847fc04e1e41f8db1f1e18ccec404e7", "id": 2}, {"size": 3, "snippet": "is defined as a candidate who enters the screening process based on Protocol defined eligibility criteria, signs the ICF and receives any Study procedure but who is not randomized or enrolled into the Study.", "snippet_links": [{"key": "screening-process", "type": "clause", "offset": [41, 58]}, {"key": "based-on", "type": "clause", "offset": [59, 67]}, {"key": "eligibility-criteria", "type": "clause", "offset": [85, 105]}, {"key": "study-procedure", "type": "clause", "offset": [138, 153]}, {"key": "the-study", "type": "definition", "offset": [197, 206]}], "samples": [{"hash": "5MnAv9AJAYD", "uri": "/contracts/5MnAv9AJAYD#screen-failure", "label": "Clinical Study Agreement", "score": 25.90347759, "published": true}, {"hash": "4ovsWPDRrrl", "uri": "/contracts/4ovsWPDRrrl#screen-failure", "label": "Clinical Study Agreement", "score": 23.9069130732, "published": true}], "hash": "50f728aa4c9b6b81957dad4bfda04b0a", "id": 3}, {"size": 3, "snippet": "means a subject has, at a minimum, signed the informed consent document for the Study, but does not [Enroll or Randomize] into the Study. 11 655,00", "snippet_links": [{"key": "informed-consent-document", "type": "definition", "offset": [46, 71]}, {"key": "the-study", "type": "definition", "offset": [76, 85]}], "samples": [{"hash": "4eLm43cTwM8", "uri": "/contracts/4eLm43cTwM8#screen-failure", "label": "Clinical Study Agreement", "score": 29.3078710794, "published": true}], "hash": "4e10a796e2dfba141b0fa07f61362f66", "id": 4}, {"size": 2, "snippet": "means a Study subject who - was not obviously ineligible, - has completed the Screening Visit procedures as outlined in the Protocol (including, without limitation, the informed consent process) and - is not randomised into the study as it failed to meet the criteria for randomisation and has not received any dose of the Study Drug. - will be reimbursed at amount EUR Payment for screen failures will be made by CRO after CRO has received and reviewed all appropriate eCRFs (data has been entered, or documentation of procedures completed) in addition to any other information that is requested by Sponsor to appropriately document the Study subject screening procedures. Payment for all screen compensation will be paid with the next scheduled payment owed to the Investigator.", "snippet_links": [{"key": "study-subject", "type": "definition", "offset": [8, 21]}, {"key": "visit-procedures", "type": "clause", "offset": [88, 104]}, {"key": "the-protocol", "type": "clause", "offset": [120, 132]}, {"key": "without-limitation", "type": "clause", "offset": [145, 163]}, {"key": "informed-consent-process", "type": "clause", "offset": [169, 193]}, {"key": "the-study", "type": "definition", "offset": [224, 233]}, {"key": "the-criteria", "type": "clause", "offset": [255, 267]}, {"key": "study-drug", "type": "definition", "offset": [323, 333]}, {"key": "screen-failures", "type": "definition", "offset": [382, 397]}, {"key": "by-cro", "type": "clause", "offset": [411, 417]}, {"key": "in-addition-to", "type": "clause", "offset": [542, 556]}, {"key": "other-information", "type": "definition", "offset": [561, 578]}, {"key": "by-sponsor", "type": "clause", "offset": [597, 607]}, {"key": "screening-procedures", "type": "clause", "offset": [652, 672]}, {"key": "payment-for-all", "type": "clause", "offset": [674, 689]}, {"key": "payment-owed", "type": "clause", "offset": [747, 759]}, {"key": "the-investigator", "type": "clause", "offset": [763, 779]}], "samples": [{"hash": "8DeRIXc0u76", "uri": "/contracts/8DeRIXc0u76#screen-failure", "label": "Clinical Study Agreement", "score": 26.9875558278, "published": true}], "hash": "491e87dca9ba6f35449b3d75e321ce22", "id": 5}, {"size": 2, "snippet": "A Screen Failure shall be defined as a Study Participant who has signed an Informed Consent but could not be effectively included in the Study under the inclusion/exclusion criteria or for other reasons. A maximum of 2 (two) Screen Failures shall be paid during the study at a rate of \u20ac 238 (two hundred and thirty eight Euro) for S-01 and \u20ac 121 (one hundred and twenty one Euro) for S-02 per Screen Failure Study Participant. Ne\u00faspe\u0161n\u00e9 zaradenie: Ne\u00faspe\u0161n\u00e9 zaradenie do sk\u00fa- \u2587\u2587\u2587\u2587\u2587 sa definuje ako tak\u00fd \u00fa\u010dastn\u00edk klinick\u00e9ho sk\u00fa\u0161a- nia, ktor\u00fd podp\u00edsal Informovan\u00fd s\u00fahlas, ale pod\u013ea krit\u00e9ri\u00ed pre zaradenie/vyradenie alebo z in\u00fdch d\u00f4vodov nemohol by\u0165 zaraden\u00fd do sk\u00fa\u0161ania. Maxim\u00e1lny po\u010det 2 ne\u00faspe\u0161n\u00fdch zaraden\u00ed bude preplaten\u00fd po\u010das sk\u00fa\u0161a- \u2587\u2587\u2587 \u2587\u2587 v\u00fd\u0161ke \u20ac 238 (dvestotridsa\u0165osem Eur) pre S-01 a \u20ac 121 (stodvadsa\u0165jeden Eur) pre S-02 na ne\u00faspe\u0161n\u00e9 zaradenie \u00fa\u010dastn\u00edka klinick\u00e9ho sk\u00fa\u0161ania.", "snippet_links": [{"key": "study-participant", "type": "clause", "offset": [39, 56]}, {"key": "informed-consent", "type": "clause", "offset": [75, 91]}, {"key": "in-the-study", "type": "clause", "offset": [130, 142]}, {"key": "exclusion-criteria", "type": "definition", "offset": [163, 181]}, {"key": "for-other-reasons", "type": "clause", "offset": [185, 202]}, {"key": "screen-failures", "type": "definition", "offset": [225, 240]}, {"key": "during-the-study", "type": "clause", "offset": [255, 271]}, {"key": "rate-of", "type": "clause", "offset": [277, 284]}, {"key": "thirty-eight", "type": "clause", "offset": [308, 320]}, {"key": "informovan\u00fd-s\u00fahlas", "type": "clause", "offset": [550, 568]}], "samples": [{"hash": "grOals9t9eD", "uri": "/contracts/grOals9t9eD#screen-failure", "label": "Clinical Trial Agreement", "score": 26.8393202977, "published": true}], "hash": "897c66fd20129dad5e7790dd3c2c12a7", "id": 6}, {"size": 2, "snippet": "A Screen Failure shall be defined as a Study Participant who has signed an Informed Consent but could not be effectively included in the Study under the inclusion/exclusion criteria or for other reasons. A maximum of 2 Screen Failures shall be paid during the study at a rate of 204,24 \u20ac per Screen Failure Subject. Ne\u00faspe\u0161n\u00e9 vstupn\u00e9 vy\u0161etrenia: Ne\u00faspe\u0161n\u00e9 vstupn\u00e9 vy\u0161etrenie je definovan\u00e9 ako \u00fa\u010dastn\u00edk sk\u00fa\u0161ania, ktor\u00fd podp\u00edsal informovan\u00fd s\u00fahlas, fakticky sa v\u0161ak nemo- hol zaradi\u0165 do sk\u00fa\u0161ania, bu\u010f na z\u00e1klade vstup- n\u00fdch/vylu\u010dovac\u00edch krit\u00e9ri\u00ed alebo z in\u00fdch d\u00f4vodov. Po\u010das sk\u00fa\u0161ania sa maj\u00fa uhradi\u0165 maxim\u00e1lne 2 ne\u00fas- pe\u0161n\u00e9 vstupn\u00e9 vy\u0161etrenia sadzbou \u20ac 204,24 na jeden subjekt, ktor\u00e9ho vstupn\u00e9 vy\u0161etrenia boli ne\u00faspe\u0161n\u00e9.", "snippet_links": [{"key": "study-participant", "type": "clause", "offset": [39, 56]}, {"key": "informed-consent", "type": "clause", "offset": [75, 91]}, {"key": "in-the-study", "type": "clause", "offset": [130, 142]}, {"key": "exclusion-criteria", "type": "definition", "offset": [163, 181]}, {"key": "for-other-reasons", "type": "clause", "offset": [185, 202]}, {"key": "screen-failures", "type": "definition", "offset": [219, 234]}, {"key": "during-the-study", "type": "clause", "offset": [249, 265]}, {"key": "rate-of", "type": "clause", "offset": [271, 278]}, {"key": "informovan\u00fd-s\u00fahlas", "type": "clause", "offset": [427, 445]}], "samples": [{"hash": "52N2jKfl7hV", "uri": "/contracts/52N2jKfl7hV#screen-failure", "label": "Clinical Trial Agreement", "score": 27.4361190905, "published": true}], "hash": "f61f73ac0927d9384ade20aacd08a472", "id": 7}, {"size": 1, "snippet": "A Screen Failure shall be defined as a Study Participant who has signed an Informed Consent but could not be effectively included in the Study under the inclusion/exclusion criteria or for other reasons. A maximum of 2 (two) Screen Failures shall be paid during the study at a rate of \u20ac 230 (two hundred and thirty Euro) per Screen Failure Study Participant. Ne\u00faspe\u0161n\u00e9 zaradenie: Ne\u00faspe\u0161n\u00e9 zaradenie do sk\u00fa- \u2587\u2587\u2587\u2587\u2587 je tak\u00fd \u00fa\u010dastn\u00edk sk\u00fa\u0161ania, ktor\u00fd podp\u00edsal infor- movan\u00fd s\u00fahlas, ale pod\u013ea krit\u00e9ri\u00ed pre zarade- nie/vyradenie alebo z in\u00fdch d\u00f4vodov nemohol by\u0165 zaraden\u00fd do sk\u00fa\u0161ania. Maxim\u00e1lny po\u010det 2 ne\u00faspe\u0161- n\u00fdch zaraden\u00ed bude preplaten\u00fd po\u010das \u0160t\u00fadie vo v\u00fd\u0161ke \u20ac 230 (dvestotridsa\u0165 Eur) na ne\u00faspe\u0161n\u00e9 zaradenie \u00fa\u010dastn\u00edka sk\u00fa\u0161ania.", "snippet_links": [{"key": "study-participant", "type": "clause", "offset": [39, 56]}, {"key": "informed-consent", "type": "clause", "offset": [75, 91]}, {"key": "in-the-study", "type": "clause", "offset": [130, 142]}, {"key": "exclusion-criteria", "type": "definition", "offset": [163, 181]}, {"key": "for-other-reasons", "type": "clause", "offset": [185, 202]}, {"key": "screen-failures", "type": "definition", "offset": [225, 240]}, {"key": "during-the-study", "type": "clause", "offset": [255, 271]}, {"key": "rate-of", "type": "clause", "offset": [277, 284]}], "samples": [{"hash": "8ABRmEHKhDK", "uri": "/contracts/8ABRmEHKhDK#screen-failure", "label": "Clinical Trial Agreement", "score": 27.1650957855, "published": true}], "hash": "2a0a2822da97ba31157d19575095a379", "id": 8}, {"size": 1, "snippet": "is a consented subject who fails to meet the screening visit criteria and is thus not eligible for enrollment into the Study. Screen Failures will be reimbursed as outlined in Exhibit 1. To receive payment for Screen Failures, the Screening CRFs must be completed. Institution shall request payment for each Screen Failure in accordance with Section 12 (Invoices & Payments), specifying the candidate\u2019s screening number (or other unique identifier) za ka\u017ed\u00fd subjekt, kter\u00fd nepro\u0161el screeningem, v souladu s odstavcem 12 (Faktury a platby) a uvede p\u0159i tom screeningov\u00e9 \u010d\u00edslo kandid\u00e1ta (nebo jin\u00fd jedine\u010dn\u00fd identifika\u010dn\u00ed \u00fadaj) a datum ne\u00fasp\u011b\u0161n\u00e9ho screeningu. and the date of the Screen Failure.", "snippet_links": [{"key": "screening-visit", "type": "clause", "offset": [45, 60]}, {"key": "not-eligible", "type": "definition", "offset": [82, 94]}, {"key": "the-study", "type": "definition", "offset": [115, 124]}, {"key": "screen-failures", "type": "definition", "offset": [126, 141]}, {"key": "exhibit-1", "type": "clause", "offset": [176, 185]}, {"key": "to-receive", "type": "definition", "offset": [187, 197]}, {"key": "payment-for", "type": "clause", "offset": [198, 209]}, {"key": "must-be-completed", "type": "clause", "offset": [246, 263]}, {"key": "institution-shall", "type": "clause", "offset": [265, 282]}, {"key": "in-accordance-with", "type": "definition", "offset": [323, 341]}, {"key": "section-12", "type": "definition", "offset": [342, 352]}, {"key": "the-candidate", "type": "definition", "offset": [387, 400]}, {"key": "unique-identifier", "type": "definition", "offset": [430, 447]}, {"key": "date-of", "type": "clause", "offset": [665, 672]}], "samples": [{"hash": "gwoThwiDgdH", "uri": "/contracts/gwoThwiDgdH#screen-failure", "label": "Clinical Trial Agreement", "score": 26.726899384, "published": true}], "hash": "2a8940a14d5f7a0987c98170ba9b2789", "id": 9}, {"size": 1, "snippet": "means a Subject has, at a minimum, signed the informed consent and authorization document for the Study, but does not enroll or randomize into the Study. Screen Failure payments will be made along with Subject Visit Payments, as described below. Not to Exceed $Insert Amount Subject Visit Payments: Payments for subject visits will be made US: monthly, Non-US: quarterly following enrollment of the first Subject. Payments will be made after data is entered by INSTITUTION into the CRFs and reviewed by ABBOTT, and will correspond to amounts listed in Attachment I to Appendix I. INSTITUTION understands that such payments are subject to subsequent verification by ABBOTT and will be adjusted per Section 8 (Compensation) of the Master Agreement if necessary. Checks shall be made payable to (Must be exact name as it appears on the IRS tax form): Federal Employer ID Number: Insert Payee Insert Number Individual and Address to receive Payment at INSTITUTION: Insert Name Insert Address Name and e-mail address of Individual at INSTITUTION to receive detailed payment information: Insert Name Insert e-mail address Individual and Address to receive Invoices at ABBOTT: Payment Specialist \u2587\u2587\u2587\u2587\u2587\u2587 Laboratories Dept. \u2587\u2587\u2587\u2587, \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587-\u2587 \u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587 Road \u2587\u2587\u2587\u2587\u2587\u2587 Park, IL 60064-6145 \u2587\u2587\u2587\u2587\u2587\u2587_\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587@\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587 If sending electronically, please be sure to include the Study number on the subject line of the e-mail. If the invoice is not study-specific, please include the 5- digit contract number located in the lower left-hand corner of the Statement of Work \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 Director Office of Industry Engagement The University of Texas at Austin \u2587.\u2587. \u2587\u2587\u2587 \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587, \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587-\u2587\u2587\u2587\u2587 Overnight address: \u2587\u2587\u2587 \u2587. \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 North Office Bldg. A (NOA), \u2587\u2587\u2587\u2587\u2587 \u2587.\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587, \u2587\u2587 \u2587\u2587\u2587\u2587\u2587 Phone: \u2587\u2587\u2587-\u2587\u2587\u2587-\u2587\u2587\u2587\u2587 Fax: \u2587\u2587\u2587-\u2587\u2587\u2587-\u2587\u2587\u2587\u2587 Tax ID: 74-600023 \u2587\u2587\u2587\u2587\u2587\u2587 \u2587. \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587, \u2587.\u2587. Vice President for Research Administration The University of Texas Southwestern Medical Center \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 Blvd. Dallas, Texas \u2587\u2587\u2587\u2587\u2587-\u2587\u2587\u2587\u2587 Phone: \u2587\u2587\u2587-\u2587\u2587\u2587-\u2587\u2587\u2587\u2587 Fax: \u2587\u2587\u2587-\u2587\u2587\u2587-\u2587\u2587\u2587\u2587 Tax ID: \u2587\u2587-\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587 \u2587. \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 Assistant Vice President for Research and Sponsored Programs The University of Texas Health Science Center at San Antonio 7703 \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587 Dr, Mail Code \u2587\u2587\u2587\u2587 \u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587, \u2587\u2587 \u2587\u2587\u2587\u2587\u2587-\u2587\u2587\u2587\u2587 Phone: \u2587\u2587\u2587-\u2587\u2587\u2587-\u2587\u2587\u2587\u2587 Fax: \u2587\u2587\u2587-\u2587\u2587\u2587-\u2587\u2587\u2587\u2587 Tax ID: \u2587\u2587-\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 Assistant Director, Contracts, Office of Sponsored Projects The University of Texas Health Science Center at Houston \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587, Suite 1006 Houston, TX 77030 Phone: \u2587\u2587\u2587-\u2587\u2587\u2587-\u2587\u2587\u2587\u2587 Fax: \u2587\u2587\u2587-\u2587\u2587\u2587-\u2587\u2587\u2587\u2587 Tax ID: \u2587\u2587-\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 Director, Office of Pre-Award Services The University of Texas Health Science Center at Tyler \u2587\u2587\u2587\u2587\u2587 \u2587.\u2587. \u2587\u2587\u2587. \u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587, \u2587\u2587 \u2587\u2587\u2587\u2587\u2587-\u2587\u2587\u2587\u2587 Phone: \u2587\u2587\u2587-\u2587\u2587\u2587-\u2587\u2587\u2587\u2587 Fax: \u2587\u2587\u2587-\u2587\u2587\u2587-\u2587\u2587\u2587\u2587 Tax ID: \u2587\u2587-\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 Manager of Research Operations The University of Texas Medical Branch at Galveston Office of Sponsored Projects \u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 4.40 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 Hospital \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587, \u2587\u2587 \u2587\u2587\u2587\u2587\u2587-\u2587\u2587\u2587\u2587 Phone: \u2587\u2587\u2587-\u2587\u2587\u2587-\u2587\u2587\u2587\u2587 Fax: \u2587\u2587\u2587-\u2587\u2587\u2587-\u2587\u2587\u2587\u2587 Tax ID: \u2587\u2587-\u2587\u2587\u2587\u2587\u2587\u2587\u2587", "snippet_links": [{"key": "authorization-document", "type": "definition", "offset": [67, 89]}, {"key": "the-study", "type": "definition", "offset": [94, 103]}, {"key": "failure-payments", "type": "clause", "offset": [161, 177]}, {"key": "subject-visit-payments", "type": "clause", "offset": [202, 224]}, {"key": "not-to-exceed", "type": "definition", "offset": [246, 259]}, {"key": "insert-amount", "type": "clause", "offset": [261, 274]}, {"key": "payments-for", "type": "clause", "offset": [299, 311]}, {"key": "by-institution", "type": "clause", "offset": [458, 472]}, {"key": "reviewed-by", "type": "definition", "offset": [491, 502]}, {"key": "attachment-i", "type": "clause", "offset": [552, 564]}, {"key": "subject-to", "type": "definition", "offset": [627, 637]}, {"key": "section-8", "type": "definition", "offset": [697, 706]}, {"key": "the-master-agreement", "type": "clause", "offset": [725, 745]}, {"key": "payable-to", "type": "definition", "offset": [781, 791]}, {"key": "tax-form", "type": "definition", "offset": [837, 845]}, {"key": "and-address", "type": "definition", "offset": [914, 925]}, {"key": "to-receive", "type": "definition", "offset": [926, 936]}, {"key": "insert-name", "type": "clause", "offset": [961, 972]}, {"key": "mail-address", "type": "definition", "offset": [999, 1011]}, {"key": "payment-information", "type": "clause", "offset": [1061, 1080]}, {"key": "the-subject", "type": "clause", "offset": [1381, 1392]}, {"key": "line-of", "type": "definition", "offset": [1393, 1400]}, {"key": "the-e", "type": "clause", "offset": [1401, 1406]}, {"key": "contract-number", "type": "definition", "offset": [1479, 1494]}, {"key": "located-in", "type": "definition", "offset": [1495, 1505]}, {"key": "statement-of-work", "type": "definition", "offset": [1540, 1557]}, {"key": "industry-engagement", "type": "clause", "offset": [1590, 1609]}, {"key": "the-university", "type": "definition", "offset": [1610, 1624]}, {"key": "research-administration", "type": "clause", "offset": [1887, 1910]}, {"key": "medical-center", "type": "clause", "offset": [1948, 1962]}, {"key": "assistant-vice-president", "type": "clause", "offset": [2085, 2109]}, {"key": "sponsored-programs", "type": "definition", "offset": [2127, 2145]}, {"key": "health-science-center", "type": "definition", "offset": [2170, 2191]}, {"key": "san-antonio", "type": "definition", "offset": [2195, 2206]}, {"key": "assistant-director", "type": "definition", "offset": [2342, 2360]}], "samples": [{"hash": "dZkct1BlIvL", "uri": "/contracts/dZkct1BlIvL#screen-failure", "label": "Master Clinical Study Agreement", "score": 26.1704312115, "published": true}], "hash": "4af9ded8e3e2770015d4d801af333526", "id": 10}], "next_curs": "ClsSVWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjcLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIXc2NyZWVuLWZhaWx1cmUjMDAwMDAwMGEMogECZW4YACAA", "definition": {"size": 37, "snippet": "is a Study Subject who is not enrolled into the Study because he or she does not meet all inclusion and exclusion criteria or other requirements that must be met for participation in the Study. \u201eP\u0159\u00edpadem ne\u00fasp\u011b\u0161n\u00e9ho screeningu\u201c se rozum\u00ed Subjekt studie, kter\u00fd nebyl do Studie zaps\u00e1n, jeliko\u017e nevyhov\u011bl v\u0161em krit\u00e9ri\u00edm pro za\u0159azen\u00ed a vylou\u010den\u00ed nebo jin\u00fdm po\u017eadavk\u016fm, kter\u00e9 mus\u00ed b\u00fdt k \u00fa\u010dasti ve Studii spln\u011bny.", "title": "Screen Failure", "id": "screen-failure", "examples": ["A <strong>Screen Failure</strong> is a consented Trial Subject who fails to meet the screening visit criteria and is thus not eligible for enrollment into the Trial.", "A <strong>Screen Failure</strong> is a consented Trial Subject who fails to meet the screening visit criteria and is thus not eligible for enrollment into the Trial (\u201c<strong>Screen Failure</strong>\u201d).", "<strong>Screen Failure</strong> je Subjekt hodnocen\u00ed, kter\u00fd ji\u017e ud\u011blil souhlas se za\u0159azen\u00edm do Studie a kter\u00fd nesplnil krit\u00e9ria screeningov\u00e9 n\u00e1v\u0161t\u011bvy a \u2587\u2587\u2587 nen\u00ed zp\u016fsobil\u00fd k za\u0159azen\u00ed do Studie.", "A <strong>Screen Failure</strong> is a consented Trial Subject who fails to meet the screening visit criteria and is thus not eligible for enrolment into the Trial.", "The Trial Site will receive payment per <strong>Screen Failure</strong> for an initial [X] <strong>Screen Failures</strong>.", "If the parties mutually agree in writing (including email) to change the approved number of allowable <strong>Screen Failure</strong> payments during the course of the study, an amendment to this Agreement is not required.", "All costs associated with each <strong>Screen Failure</strong> are payable by the Sponsor or its Agent on a pro rata basis as per the individual task price set out in the below Finance Schedule.", "A <strong>Screen Failure</strong> is a consented Study subject who fails to meet the screening visit criteria and is thus not eligible for enrollment into the Study.", "A <strong>Screen Failure</strong> is a consented Study Participant who fails to meet the screening visit criteria and is thus not eligible for enrolment into the Study (\u201c<strong>Screen Failure</strong>\u201d).", "For purposes of this Agreement, a <strong>Screen Failure</strong> shall mean a subject who (i) completes the Screening Visit procedures outlined in the Protocol (including, without limitation, the informed consent process) and (ii) is not randomized."], "related": [["mi-failure", "MI Failure", "MI Failure"], ["gep-failure", "GEP Failure", "GEP Failure"], ["transaction-failure", "Transaction Failure", "Transaction Failure"], ["volume-failure", "Volume Failure", "Volume Failure"], ["conversion-failure", "Conversion Failure", "Conversion Failure"]], "related_snippets": [], "updated": "2025-07-07T00:35:48+00:00"}, "json": true, "cursor": ""}}